Kent Meningitis Outbreak Grows to 27 Cases With Two Dead
Health authorities are racing to contain an unprecedented meningitis outbreak in Kent that has now reached 27 cases, killed two young people, and spread to students at two universities and four schools.
As of 18th March, the UK Health Security Agency has confirmed 15 laboratory cases with a further 12 still under investigation. Two people have died — a school pupil and a University of Kent student — with no further deaths reported since the last update. A student at a higher education institution in London has also been confirmed as part of the outbreak, and is directly linked to the Kent cluster.
Health Secretary Wes Streeting described the outbreak as unprecedented, and Prime Minister Keir Starmer told Parliament it was "a deeply difficult time" for the families affected. Officials say this is the fastest-growing outbreak that they have ever seen.
At the centre of the outbreak is Club Chemistry, a Canterbury nightclub popular with students. At least ten cases have been traced back to visits to the nightclub between the 5th and 7th March, and GPs across England have been told to prescribe preventative antibiotics to anyone who attended during that period. The antibiotics are being made available through GPs nationwide so students who have since travelled home can still access them without returning to Kent.
The UKHSA's chief scientific officer Prof Robin May said that the scale of the outbreak was baffling. "What is particularly remarkable about this case, and unexpected about this case, is the large number of cases all originating from what seems to be a single event," he told BBC Breakfast. He said two possible explanations were being explored: either certain behaviours among individuals were driving transmission, or the bacteria itself "may have evolved to be better at transmitting."
More than 6,500 precautionary doses of antibiotics have been issued to students, and a targeted vaccination programme has now begun at the University of Kent's Canterbury campus, with around 5,000 students eligible and 600 doses administered so far. The UKHSA has been clear about the vaccine's limitations, however.
UKHSA Regional Deputy Director Trish Mannes said: "Two doses of the MenB vaccine helps protect individuals against meningococcal B disease. It is important to know that the MenB vaccine does not protect against all strains of meningococcal disease, nor against all infections that can cause meningitis. It also does not prevent the bacteria from being carried and spread in the community."
She urged anyone who is offered preventative antibiotics to take them promptly, and told University of Kent students who have left campus to contact their local GP. "It is…still hugely important that people are aware of the signs and symptoms of invasive meningococcal disease, and that they seek immediate medical attention if they or anyone they know develops these signs and symptoms," Mannes added.
Streeting said that in 90% of cases, antibiotics are an effective preventative treatment, and that contact tracing had been carried out proactively. Immunity from the MenB vaccine takes around two weeks to develop.
The disease is spread through close contact such as kissing, sharing drinks or vapes, or living in shared housing all increase risk. The bacteria typically lives harmlessly in people's throats but can become life-threatening if it enters the blood or spinal fluid. Around one in 20 people who develop meningococcal disease will die, with higher mortality rates among teenagers and young adults. Canterbury Christ Church University confirmed one of its students had contracted meningitis, though all reported cases so far have a link to Kent.
The UKHSA said the NHS is well stocked with MenB vaccines after some pharmacies reported difficulty sourcing the jab for people seeking to pay for it privately. Authorities stressed that a wider NHS alert about symptoms does not indicate the outbreak is expected to spread nationally, and that the risk to the general public remains low.
Early warning signs to watch for include sudden high fever, a severe and worsening headache, stiff neck, sensitivity to light, vomiting, cold hands and feet, confusion and extreme drowsiness. The most distinctive sign of meningococcal septicaemia is a rash that does not fade when a glass is pressed against it.
